FDA Approves Drug for Crohn's Diseasehttp://articles.mercola.com/sites/articles/archive/2008/01/02/drug-for-crohns.aspxThe US Food and Drug Administration (FDA) has approved a new biotechnology product -- a monoclonal antibody -- for use in treating moderate to severe Crohn's disease, a chronic inflammatory bowel disease. The drug, known as infliximab (Remicade), reducesenCommunityServer 2008.5 SP1 (Build: 31106.3070)